The Effect of Propolis Administration on Cholesterol Level in Diabetic Type 2 Patients
The Effect of Propolis Administration on Low Density Lipoprotein and High Density Lipoprotein in Diabetic Type 2 Patients in Central Jakarta
Indonesia University
64 participants
Mar 18, 2025
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to learn if propolis administration works to change the level of Low Density Lipoprotein (LDL) and High Density Lipoprotein cholesterol (HDL) in diabetic type 2 patients. The main questions it aims to answer are: \- Is giving 1 drops/ 10kg/ times, twice daily for 8 weeks will change the level of LDL and HDL level in diabetic type 2 patients compared to placebo? Researchers will compare propolis to a placebo (a look-alike substance that contains no drug) to see if propolis works to change LDL and HDL cholesterol level. Participants will: * Take propolis or a placebo, 2 times daily with given dose (1 drops/10 kg/times) every day for 2 months * Visit the sub-district health centre once every 2 weeks for checkups * Get their blood checked before and after intervention
Eligibility
Inclusion Criteria3
- Controlled Diabetes Mellitus type 2 with HbA1c \<7.5%
- BMI 23-35 kg/m2
- On anti-cholesterol therapy
Exclusion Criteria7
- Using injection therapy (insulin or GLP-1 RA)
- History of bees product allergy
- Active smoker
- Consuming alcohol
- Altered liver (ALT\>35 IU/L) and kidney (eGFR\<90 mL/min) function
- Pregnant and breastfeeding women
- History of cardiovascular disease (heart attack, stroke)
Interventions
The intervention given is propolis drops that are approved by Indonesian Food and Drug Authority
The given placebo are look-alike substance with no effect
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06903546